Prognostic value of E-cadherin expression in thyroid follicular carcinoma

European Journal of Surgical Oncology

Volumn 31, Issue 5, 2005, Pages 544-548

  Brecelj, E ^a   Grazio, S Frković ^a   Auersperg, M ^a   Bracko M ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

E cadherin; Follicular carcinoma; Thyroid

Indexed keywords

PARAFFIN; UVOMORULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL MEMBRANE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THYROID FOLLICULAR CARCINOMA; TISSUE SECTION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 19444376863     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.02.003     Document Type: Article

References (15)

1. M. Takeichi Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 1991 1451-1455
2. E. Van Aken O. De Wever A.S. Correia da Rocha M. Mareel Defective E-cadherin/catenin complexes in human cancer Virchows Arch 439 2001 725-751
3. G. Brabant C. Hoang-Vu Y. Cetin H. Dralle G. Scheumann J. Molne et al. E-cadherin: A differentiation marker in thyroid malignancies Cancer Res 53 1993 4987-4993
4. T. Dahlman L. Grimelius G. Wallin K. Rubin K. Westermark Integrins in thyroid tissue: Upregulation of alpha2beta1 in anaplastic thyroid carcinoma Eur J Endocrinol 138 1998 104-112
5. S.H. Huang J.C. Wu K.J. Chang K.Y. Liaw S.M. Wang Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue Thyroid 9 1999 1095-1103
6. A. Naito H. Iwase T. Kuzushima T. Nakamura S. Kobayashi Clinical significance of E-cadherin expression in thyroid neoplasms J Surg Oncol 76 2001 176-180
7. A.S. Rocha P. Soares E. Fonseca J. Cameselle-Teijeiro M.C. Oliveira M. Sobrinho-Simoes E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas Histopathology 42 2003 580-587
8. J.R. Graff V.E. Greenberg J.G. Herman W.H. Westra E.R. Boghaert K.B. Ain et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma Cancer Res 58 1998 2063-2066
9. N. Kato T. Tsuchiya G. Tamura T. Motoyama E-cadherin expression in follicular carcinoma of the thyroid Pathol Int 52 2002 13-18
10. G.F. Scheumman C. Hoang-Vu Y. Cetin O. Gimm J. Behrends R. von Wasielewski et al. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas J Clin Endocrinol Metab 80 1995 2168-2172
11. P. Soares G. Berx F. van Roy M. Sobrinho-Simoes E-cadherin gene alterations are rare events in thyroid tumors Int J Cancer 70 1997 32-38
12. S. Walgenbach E. Sternheim F. Bittinger R. Gorges J. Andreas T. Junginger Prognostische Bedeutung des e-Cadherin beim papillaren Schilddrusencarcinom Chirurg 69 1998 186-190
13. Y. Kapran N. Ozbey S. Molvalilar E. Sencer F. Dizdaroglu S. Ozarmagan Immunohistochemical detection of E-cadherin, alpha-and beta-catenins in papillary thyroid carcinoma J Endocrinol Invest 25 2002 578-585
14. R. von Wasielewski A. Rhein M. Werner G.F. Scheumann H. Dralle E. Potter et al. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome Cancer Res 57 1997 2501-2507
15. C. Hedinger E. Williams L. Sobin Histological typing of thyroid tumors World Health Organisation - international histologic classification of tumours 1988 Springer Berlin